Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Glob Health Action ; 16(1): 2183596, 2023 12 31.
Article in English | MEDLINE | ID: covidwho-2286796

ABSTRACT

BACKGROUND: Advocacy is one of the core functions of public health and is a key tool for achieving Sustainable Development Goals. Public health associations play a key role in advocating for the development and implementation of strategies to prevent diseases and promote health and well-being. OBJECTIVE: This study aims to map out the focus of public health advocacy carried out by selected national public health associations over 4 years, between 2018 and 2021, in order to identify gaps and strengths and support associations and professionals in their advocacy efforts. METHODS: Twelve national public health associations participated in the study. Official policy documents produced between 2018 and 2021 were collected and analysed. The title and summary of the policy documents were examined line by line and coded into the main subject categories and themes. A qualitative thematic analysis was conducted. Policies were assessed from global and regional perspectives. RESULTS: A total of 220 policy documents were analysed. Overall, the largest number of policy documents came from high-income countries and dealt with environmental health and communicable diseases, including COVID-19, with, however, important differences among regions. In the African region, public health advocacy focused mainly on strengthening health systems; Europe and South America were mostly concerned with communicable diseases and pandemic management; and North America and the Western Pacific regions focused primarily on climate change. Limited attention was paid to international health and health as a human right in all regions. CONCLUSION: Our study showed that, especially in high-income countries, public health associations actively engage in advocacy; however, more effort needs to be devoted to implementing a more international and intersectoral approach at the global level, anchored in health as a human right and aligned with the Sustainable Development Goals.


Subject(s)
COVID-19 , Health Promotion , Humans , Public Health , Public Policy , Health Policy
2.
Vaccines (Basel) ; 11(2)2023 Jan 31.
Article in English | MEDLINE | ID: covidwho-2260495

ABSTRACT

Vaccinations of healthcare workers (HCWs) aim to directly protect them from occupational diseases, and indirectly protect their patients and communities. However, studies increasingly highlight that HCWs can be vaccine hesitant. This review aims to analyze HCWs' and public health professionals' sentiments toward COVID-19 (Coronavirus Disease 2019) vaccination and determinants across different countries. A search strategy was conducted in PubMed using keywords such as "COVID-19", "sentiment/acceptance", "healthcare workers", "vaccine hesitancy", and "influenza". A total of 56 articles were selected for in-depth analyses. The highest COVID-19 vaccination uptake was found in an Italian study (98.9%), and the lowest in Cyprus (30%). Older age, male gender, the medical profession, higher education level, presence of comorbidities, and previous influenza vaccination were associated with vaccine acceptance. Factors for low acceptance were perceived side effects of the vaccine, perceived lack of effectiveness and efficacy, and lack of information and knowledge. Factors for acceptance were knowledge, confidence in the vaccine, government, and health authorities, and increased perception of fear and susceptibility. All studies focused on healthcare providers; no studies focusing on public health professionals' sentiments could be found, indicating a gap in research that needs to be addressed. Interventions must be implemented with vaccination campaigns to improve COVID-19 vaccine acceptance.

3.
Vaccines (Basel) ; 11(1)2023 Jan 15.
Article in English | MEDLINE | ID: covidwho-2217092

ABSTRACT

BACKGROUND: Childhood vaccination coverage has increased throughout Europe in recent decades. However, challenges persist in many areas within the European Union (EU), resulting in declining coverage rates in many countries in the period between 2010 and 2021. This general trend requires increased efforts to combat barriers around vaccination uptake. Thus, this article aims to summarise key learnings and trends in paediatric vaccination within the EU, with a focus on current challenges and enablers. METHODS: Methodology is based on analysis of primary data, mainly vaccination coverage rates, as well as review and analysis of the select relevant literature, including peer-reviewed articles, academic research papers, official reports, policies, and other publicly available sources. RESULTS: For all vaccines assessed (DTP 1st dose, DTP 3rd dose, Hib3, HepB3, measles 1st dose, measles 2nd dose, and polio 3rd dose), a high degree of variation and fluctuation in coverage can be observed. There is a general trend of declining coverage in 2019 compared to 2010, with lower performing countries, such as Romania and Austria, showing increasingly severe coverage fluctuations between the years examined across the analysed vaccines. CONCLUSIONS: Evidence suggests that increasing both accessibility and information regarding vaccines are key enablers to vaccination uptake. Moreover, given the current challenges the EU is facing, crisis preparedness plans are pertinent to ensure immunity gaps do not further exacerbate the disruption of vaccination systems.

4.
Journal of Public Health ; 30(3):649-653, 2022.
Article in English | ProQuest Central | ID: covidwho-2170371

ABSTRACT

BackgroundVaccination saves countless lives worldwide. However, a gap in accessibility to and acceptability of vaccines is observed locally and globally. This gap must be addressed through a combined intersectoral approach that takes into account different social, economic, political and environmental aspects of vaccination. In addition, a comprehensive strategy is necessary to provide better immunization to all as the Decade of Vaccines comes to an end.MethodsOne of the objectives of the World Health Organization (WHO) is to provide equitable access to quality vaccination around the world. Economic barriers as well as conflict situations lower vaccination coverage and hinder reaching the objective of having an immunization-for-all status. When resources are limited, innovative approaches to supplying vaccines are crucial for facing the challenges of our time and reaching this objective. Furthermore, an active demand for vaccination must be developed through advocacy, knowledge generation and building trust. A positive environment must be created around vaccination to reduce vaccine hesitancy and increase vaccination uptake. To increase vaccine accessibility and acceptability, the World Federation of Public Health Associations (WFPHA) developed a Call to Action based on the Global Charter for the Public's Health, which demands all actors to collaborate in creating strong health policies for vaccination.ConclusionsAn intersectoral approach is required to increase the accessibility and acceptability of vaccines. The WFPHA's Call to Action proposes strategies to reach better immunization outcomes using the Global Charter as a platform for developing better vaccination policies.

5.
J Public Health Policy ; 43(1): 174-177, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1721761
6.
Epidemiologia (Basel) ; 2(4): 519-539, 2021 Oct 23.
Article in English | MEDLINE | ID: covidwho-1480672

ABSTRACT

In late 2020 and early 2021, with the eagerly anticipated regulatory approval of vaccines against SARS-CoV-2, the urgent global effort to inoculate populations against this devastating virus was underway. These case studies examine the early stages of COVID-19 vaccine rollouts across nine regions from around the world (Brazil, India, Indonesia, Ireland, Israel, Nigeria, Taiwan, United Kingdom and United States). By evaluating and comparing different approaches used to immunize against a novel pathogen, it is possible to learn a great deal about which methods were successful, and in which areas strategies can be improved. This information is applicable to the ongoing global vaccination against this virus, as well as in the event of future pandemics. Research was conducted by following and tracking the progress of vaccine rollouts in the nine regions, using published clinical trials, government documents and news reports as sources of data. Results relate to the proportion of populations that had received at least one COVID-19 dose by 28 February 2021. Outcomes are discussed in the context of three key pillars integral to all immunization programs: procurement of vaccines, communication with the public and distribution of doses to individuals.

SELECTION OF CITATIONS
SEARCH DETAIL